Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

Katherine D. Laclair, Kebreten F. Manaye, Dexter L. Lee, Joanne S. Allard, Alena V. Savonenko, Juan C. Troncoso, Philip C. Wong

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice'. Together they form a unique fingerprint.

Medicine & Life Sciences